Catalysts for a healthier planet
About Us
Our modern lives are destroying the planet we call home. Creating a positive future requires unprecedented vision, bold action and better solutions. Epoch is combining unique insights from nature with deep expertise in computational and biological sciences to develop enzymes to unlock applications previously deemed impossible. At Epoch, scientists who have spent their entire careers working on these solutions have come together with fresh graduates to build breakthrough approaches to designing and scaling biology.
Inside Epoch
Our passion is real
We come to work every day, knowing that we will have a significant positive impact on our planet. Our motivation comes from our mission and our people: clever, spirited, opinionated, authentic personalities that we learn from and have fun with!
Selected Investors
Meet The Team
Jacob Nathan
Founder & CEO
Beatriz Lopez
CPO
Ruth Aylward
Platform Operations Scientist
Soumik Basu, PhD
Synthetic Biologist
David Clayton
Lab Technician
Catherine Fan, PhD
Strain Engineer
Elena Faull
Lab Technician
Greg Gordon, DTech
Process Chemist
Manisha Gorshia
Administration Manager
Lucy Green, PhD
Automation Scientist
Charlotte Gruender, PhD
BD Analyst
Rachel Heath, PhD
Head of Assay Development
James Johnson, PhD
Head of Molecular Biology
David Kell
ML Engineer
Giorgio Lai, PhD
Scientist
Ben Mills-Lamptey, PhD
Head of Scale Up
Chloe Millson
Lab Technician
Claire Noble, PhD
Computational Biologist
Camila Gaspar Quinonez, PhD
Assay Development Scientist
Jeremy Ramsden, PhD
Scientist
Sreenivas Ravella, PhD
Fermentation Scientist
Angela Sims, PhD
R&D Operations Project Lead
Neil Swainston, PhD
Head of Computational Biology
Dr. Thorsten Tiede
Data Engineer
Daryl Williams, PhD
Biochemist
Mike Winn, PhD
Scientist